Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Participation of host cell proteins in inclusion bodies of non-segmented RNA virus infected cells: a molecular insight. | Virol J | 2025 | 40826091 | PubTator, text mining | PubMed |
| Proteogenomic characterization of invasive breast tumors in young women. | NPJ Breast Cancer | 2025 | 40826002 | PubTator, text mining | PubMed |
| Molecular characterization of Kawasaki disease subgroups using cell-free RNA profiling. | Sci Rep | 2025 | 40813796 | PubTator, text mining | PubMed |
| Discovery of Diverse Seven-Membered Ring Vibsane Diterpenoids from Viburnum awabuki Utilizing a MassQL-Integrated Strategy and Their Antihepatoma Effect. | Org Lett | 2025 | 40757855 | PubTator, text mining | PubMed |
| A twist in the tale: shifting from covalent targeting of a tyrosine in JAK3 to a lysine in MK2. | RSC Med Chem | 2025 | 40756524 | PubTator, text mining | PubMed |
| Non-canonical Activation of RSK1 Induces EphA2-Mediated Cell Migration under Cellular Stress Conditions. | Biol Pharm Bull | 2025 | 40721370 | PubTator, text mining | PubMed |
| SARS-CoV-2-Induced Phosphorylation of HSPA9 at Ser627: Potential Implications for Mitochondrial Function, Cell Cycle Regulation, and Immune Evasion. | FASEB J | 2025 | 40693881 | PubTator, text mining | PubMed |
| Application and Cross-Validation of a High-Throughput SPR Method for Characterizing Covalent Binding Ligands. | ACS Omega | 2025 | 40687013 | PubTator, text mining | PubMed |
| [Leukocyte-specific protein 1 (LSP1): A key regulator of cytoskeletal dynamics and leukocyte function]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2025 | 40670139 | PubTator, text mining | PubMed |
| Widespread neuronal activity related to bimanual coordination in non-human primates: evidence from Fos-like activation during bimanual versus unimanual motor task. | Neurosci Insights | 2025 | 40600237 | PubTator, text mining | PubMed |
| Polymorphisms in Necroptosis Pathway Genes: Novel Prognostic Markers for Multiple Myeloma Treatment Outcomes. | Int J Mol Sci | 2025 | 40508046 | PubTator, text mining | PubMed |
| Interferon regulatory factor 8 induces intrinsic functional changes in mature neutrophils. | J Leukoc Biol | 2025 | 40457627 | PubTator, text mining | PubMed |
| Immune signatures of megakaryocytes in persistent inflammation-immunosuppression and catabolism syndrome. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40443348 | PubTator, text mining | PubMed |
| Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells. | Elife | 2025 | 40439108 | PubTator, text mining | PubMed |
| Identification of a resistance-exercise-specific signalling pathway that drives skeletal muscle growth. | Nat Metab | 2025 | 40374925 | PubTator, text mining | PubMed |
| MK2 promotes p16 negative head and neck cancer migration, invasion, and metastasis. | Cancer Lett | 2025 | 40185303 | PubTator, text mining | PubMed |
| Evaluation of the anti-leukemia activity and underlying mechanisms of the novel perinucleolar compartment inhibitor CTI-2 in acute myeloid leukemia. | Invest New Drugs | 2025 | 40095258 | PubTator, text mining | PubMed |
| Stress Response Kinase MK2 Induces Non-canonical Activation of EphA2 in EML4-ALK Lung Cancer Cells. | Biol Pharm Bull | 2025 | 40024717 | PubTator, text mining | PubMed |
| Evaluation of Pyrrolone-Fused Benzosuberene MK2 Inhibitors as Promising Therapeutic Agents for HNSCC: In Vitro Efficacy, In-Vivo Safety, and Pharmacokinetic Profiling. | Drug Dev Res | 2025 | 40009048 | PubTator, text mining | PubMed |
| Potential drug targets for ovarian cancer identified through Mendelian randomization and colocalization analysis. | J Ovarian Res | 2025 | 39972314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=4